...
首页> 外文期刊>ACS Omega >89Zr-Cobalamin PET Tracer: Synthesis, Cellular Uptake, and Use for Tumor Imaging
【24h】

89Zr-Cobalamin PET Tracer: Synthesis, Cellular Uptake, and Use for Tumor Imaging

机译:89 Zr-Cobalamin PET示踪剂:合成,细胞摄取及其在肿瘤成像中的应用

获取原文

摘要

Vitamin B_(12), or cobalamin (Cbl), is an essential nutrient. Acquisition, transport, and cellular internalization of Cbl are dependent on specific binding proteins and associated receptors. The circulating transport protein transcobalamin (TC) promotes cellular uptake via binding to specific receptors such as CD320, a receptor upregulated in several cancer cell lines. In this study, we report the successful synthesis of ~(89)Zirconium-labeled Cbl that was derivatized with desferrioxamine (~(89)Zr-Cbl). We document the purity of the tracer and its binding to TC compared with that of unmodified cyano-Cbl (CN-Cbl). In vitro studies employing the CD320 receptor-positive breast cancer cell line MDA-MB-453 showed a 6- to 10-fold greater uptake of ~(89)Zr-Cbl when compared with the uptake in the presence of 200-fold excess of CN-Cbl at 37 °C. We used nude mice with MDA-MB-453 tumors to study the feasibility of employing the tracer to visualize CD320 positive tumors. In vivo positron emission tomography images displayed a clear visualization of the tumor with 1.42 ± 0.48 %ID/g uptake (n = 3) at 4 h after injection (p.i.) with the tracer retained at 48 h p.i. Ex vivo biodistribution studies using ~(89)Zr-Cbl exhibited the highest uptake in kidney and liver at 48 h p.i. Results document the feasibility of synthesizing a Cbl-based tracer suitable for both in vivo and ex vivo studies of Cbl trafficking and with the potential to visualize tumors expressing TC receptors, such as CD320.
机译:维生素B_(12)或钴胺素​​(Cbl)是必不可少的营养素。 Cbl的获取,运输和细胞内在化取决于特异性结合蛋白和相关受体。循环转运蛋白反钴胺素(TC)通过与特定受体(例如CD320)结合而促进细胞摄取,CD320是在几种癌细胞系中上调的受体。在这项研究中,我们报告成功地合成了用去铁敏(〜(89)Zr-Cbl)衍生的〜(89)锆标记的Cbl。我们记录了示踪剂的纯度及其与TC的结合,与未修饰的氰基Cbl(CN-Cbl)相比。使用CD320受体阳性乳腺癌细胞系MDA-MB-453进行的体外研究表明,与(200)Zr-Cbl的摄取相比,存在200倍过量的〜(89)Zr-Cbl摄取高6至10倍。 CN-Cbl在37°C下。我们使用具有MDA-MB-453肿瘤的裸鼠来研究使用示踪剂可视化CD320阳性肿瘤的可行性。体内正电子发射断层扫描图像显示了清晰的肿瘤可视化,注射后(p.i.)4 h摄取的1.42±0.48%ID / g(n = 3),示踪剂在p.i 48h保留。使用〜(89)Zr-Cbl的离体生物分布研究显示p.i在肾脏和肝脏中的最高摄取量为48 h。结果证明了合成基于Cbl的示踪剂的可行性,该示踪剂适用于Cbl转运的体内和体外研究,并且具有可视化表达TC受体(例如CD320)的肿瘤的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号